RahaPharma.co

🏭Raha Pharmaceutical Co., founded in 2004 with over 30 years of combined industry experience, is one of Iran’s leading pharmaceutical manufacturers focused on innovation, therapeutic value, and quality. We offer a diversified portfolio of +180 formulations across CNS, cardiovascular, gastrointestinal, diabetic, ophthalmic, nasal, topical, and liquid dosage forms. Our capabilities include Sustained‑Release (SR), Enteric‑Coated (EC), Orally Disintegrating Tablets (ODT), ampoules, semi-solids, and liquids, all under strict GMP compliance. 🔬 In April 2019, Raha became the first company in Iran to domestically produce eight sustained-release antiepileptic tablets, generating over $3.5 million in annual revenue and achieving full substitution for imports—using 100% domestically sourced APIs 🚫🧠 farsnews.ir en.irna.ir pharmacompass.com 🚀 With 130+ proprietary formulations and a track record of launching 50+ new products in our first operational year, we continue to lead in pharmaceutical R&D and are actively expanding into regional export markets. 🌐 www.rahapharm.com